Business Name: |
Mid Florida Kidney & Hypertens |
Contact Person: |
Fuad Afzal |
Address: |
3100 Clay Avenue # 151, Orlando, Florida 32804 |
Phone Number: |
(407) 896-1789 |
Annual Revenue (USD): |
$100.000 to $499.999 |
Founding Year: |
2007 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Doctors |
SIC Code: |
8011 |
NAICS Code: |
621111 |
Share This Business: |
|
Related Businesses: |
Vidovich-Ortiz Andres MD - Orlando, FL 32804 Richard Gal Md - Orlando, FL 32804 Selsky Clifford A MD - Orlando, FL 32804 James Jeffrey A DO - Orlando, FL 32804 Surgical Specialists-Florida - Orlando, FL 32804 Orlando Aesthetic Institute - Orlando, FL 32804 John H Webb Jr Dr - Orlando, FL 32804 Sasco Industries - Orlando, FL 32804 Sollaccio Robert MD - Orlando, FL 32804 Basisht Saroj MD - Orlando, FL 32804 Pearson III Levi MD - Orlando, FL 32804 Jahagirdar Ravi R MD - Orlando, FL 32804 Sohail Ishrat MD - Orlando, FL 32804 Steven L Palmer Md - Orlando, FL 32804 Gutman Back Pain Institute Of Orlando LLC - Orlando, FL 32804 Valle Amaury O DDS - Orlando, FL 32804 Lugo Eduardo J MD - Orlando, FL 32804 Lin Yu-Hsin A MD - Orlando, FL 32804 Weissgerber Peter W MD - Orlando, FL 32804 Angelis Michael MD - Orlando, FL 32804 |
The company Mid Florida Kidney & Hypertens provides B2C services in the form of Doctors from its single location in Florida.
1 to 4 employees work for Mid Florida Kidney & Hypertens, and the business now earns $100.000 to $499.999 per annum.
Mid Florida Kidney & Hypertens was launched in 2007 and is classified under SIC code and category 8011 , and NAICS number and grouping 621111 .
To contact Mid Florida Kidney & Hypertens, please call Fuad Afzal with the phone number (407) 896-1789 or visit its single location at 3100 Clay Avenue # 151 in Orlando, Florida 32804.
The location of the single location can also be found using the coordinates .
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.